News – 2019
November 10, 2019
Using the Vagus Nerve to Help Hearing
Given its key role in sending or mediating sensory information throughout the body to the brain, the vagus nerve has long interested researchers as a target for potential intervention for myriad conditions. Such research has paid off.
September 13, 2019
Podcast featuring Dr. Michael S. Borland and Dr. Crystal Engineer
Previous studies have reported primary auditory cortex plasticity following vagus nerve stimulation (VNS) paired with a sound. Does this phenomenon extend to other fields in the auditory pathway? In this podcast, Editor-in-Chief Bill Yates talks with Dr. Michael S. Borland and Dr. Crystal Engineer (both from the University of Texas at Dallas) about their recent study, which is the first to document both cortical and subcortical plasticity following VNS-sound pairing. Listen to learn about auditory plasticity, potential therapies for auditory processing disorders, and more!
August 8, 2019
TxBDC Graduate Student Awarded Matthew S. Perry Fellowship
Graduate student Robert Morrison was recently awarded the Matthew S. Perry Fellowship in Cognition and Neuroscience which supports graduate students pursuing degrees in Neuroscience and Cognition in the School of Behavioral and Brain Sciences. Robert’s research focuses on optimizing Targeted Plasticity Therapy, which enhances recovery after a neurological injury or disease.
July 9, 2019
TxBDC Undergraduate Research Program Forges Path to Medical School
Student researcher Mian Bilal began his career at TxBDC during his freshman year. He spent most of his time gaining experience in animal behavior, data collection, surgical implants, and mapping.
June 27, 2019
Patrick Ganzer, PhD Receives the King’s College Leo Award
Patrick Ganzer, PhD, former research fellow at the Texas Biomedical Device Center (TxBDC) was presented with the King’s College Leo Award earlier this month. The Leo Award is presented to alumna within 15 years of their graduation who have demonstrated outstanding achievement in their professional or community activities.
May 24, 2019
Dr. Seth Hays comments on the future of stroke therapy
New treatments are definitely needed for stroke patients, Dr. Seth Hays said: “Although remarkable advances have been made in acute stroke treatment, stroke is still a leading cause of disability.” Additionally, some patients are ineligible for existing treatments, but neurostimulation may be used with a large population, he said.
May 23, 2019
Research Program Prepares Students for Life After College
Participating in the Texas Biomedical Device Center’s Undergraduate Research Program is an excellent way for UT Dallas students to strengthen their academic experience and prepare for post-graduate life.
February 20, 2019
The Texas Biomedical Device Center was awarded a grant worth up to $3.5 million from the National Institutes of Health to support wireless nerve stimulation to enhance recovery after stroke. Read the story.
February 1, 2019
We are excited to announce that today after two years of hard work we submitted to the Food and Drug Administration two Investigational Device Exemptions (IDE) for our wireless vagus nerve stimulator called ReStore. This implantable biomedical device, entirely developed at The University of Texas at Dallas, with our commercial partner Teliatry, Inc. will allow us to perform clinical trials using Targeted Plasticity Therapy to restore functions lost as a result of neurological injuries and disease. Read the newsletter.
January 30, 2019
Robert Morrison, graduate student at the TxBDC was recently awarded $1,000 in the Open Science Framework’s Preregistration Challenge. This education campaign was supported by the Laura and John Arnold Foundation and included $1,000 prizes for researchers who published the results of preregistered work. Read the story.
January 25, 2019
It is an exciting time for the Texas Biomedical Device Center. Just six years ago we embarked on this incredible journey to improve the lives of those suffering from neurological injuries. In that short time our team has published over 100 peer-reviewed papers, trained hundreds of students to conduct rigorous research, raised over $37 million in external funding, and treated 150 people using Targeted Plasticity Therapy in 5 clinical trials. Read the announcement.
